Full-Time

Pharmacovigilance Services Analyst

Accenture

Accenture

10,001+ employees

Global professional services and technology consulting

No salary listed

Chennai, Tamil Nadu, India

In Person

Category
Biology & Biotech (2)
,
Requirements
  • Bachelor of Pharmacy/Bachelor of Science in Nursing
  • Bachelor’s Degree in Life Sciences
  • 3 to 5 years of experience
  • Technology skills: experience with MS Office, knowledge of safety database
  • Good knowledge of medical terminology including dictionaries like MedDRA and WHO-Drug (preferred)
  • Good medical writing skills
  • Good communication skills
  • Strong English language proficiency (Reading, Writing, Listening and Speaking)
Responsibilities
  • Prioritise, book in, triage, and case processing activities for Individual Case Safety Reports in accordance with Client Guidelines, Regulatory due date, and Turn-Around Time SLAs and KPIs; case processing includes end to end processing as per client requirements and case processing guidelines.
  • Prioritise cases from Intake workflow, mails and other sources to create cases in global safety database, identify, review for validity of cases and move to respective workflow step based on case type as per defined timelines.
  • Perform collection, evaluation, and submission of Adverse Event reports, transmission, and reconciliation of pharmacovigilance data of individual case reports including TMF review, download of AE reports from EVWEB and MHRA portal and importing AE reports into the pharmacovigilance database.
  • Review source documents for validity of ICSR, perform duplicate check in intake workflow/safety database, confirm information is medically significant or relevant and take necessary actions per Client SOPs.
  • Request missing minimum safety information or clarification, send queries per Client SOP and guidelines from Marketing Company or reporter as applicable.
  • Complete case processing of safety information including coding of medical history, suspect drug, adverse event and drafting narrative into Global Safety Database from source documents.
  • Assess adverse events for seriousness, causality as per Client SOPs, consulting medical reviewer/validator as needed.
  • Perform medical coding/Drug coding for each ICSR in accordance with Client Guidelines and SOPs using MedDRA and WHODD
  • Complete and review evaluation of the case including causality, prepare narrative and E2B sender’s comments as per Client SOP.
  • Processing all AEs, SAEs, and SUSARs in the Global Safety Database according to company policies and SOPs.
  • Drafting pharmacovigilance agendas and meeting minutes; archiving pharmacovigilance documents; reviewing safety case data for completeness and accuracy.
  • Assisting with tracking, submitting and distributing reports; liaising with partners and cross-functional teams to ensure compliance; supporting ad-hoc deliverables and pharmacovigilance projects; participating in audits/inspections.
  • Validate data consistency and make corrections as needed.
  • Determine if additional information is needed and obtain missing information as per Client SOP.
  • Check pending actions, follow-up, clarifications, corrections and ensure resolution and closure of cases.
  • Perform submissions in global safety database for all AEs, SAEs, SUSARs; monitor submission related client reports and troubleshoot issues.
  • Perform translations of source documents, case narratives, adverse events as applicable.
  • Monitor, track and reconcile client mailboxes and other sources; perform paper and electronic unblinding if required as per Client SOP.
  • Review responses to queries and add follow-up information to case narrative and fields as required.
  • Review and perform case corrections, deletions as per SOPs and guidance; close action items.
  • Archive all communications/clarifications related to the Case in the Global Safety Database.
  • Escalate issues outside normal scope to lead; escalate to service delivery lead/operations lead if needed.
  • Note: role may require rotational shifts

Accenture is a global professional services firm that helps companies navigate technology-driven change. It offers strategies and services across consulting, digital, technology, and operations, with a strong emphasis on cloud, artificial intelligence, security, and enterprise reinvention. Accenture works by delivering end-to-end solutions, combining advisory work with implementation, technology platforms, and managed services to transform how organizations operate and compete in today’s digital world. The company differentiates itself through its long history as a dedicated tech-advisory arm that gained independence in 2001, its scale, and its active acquisitions—particularly since 2013—to expand capabilities in digital, cloud, and security. Its goal is to help the world’s largest corporations rethink and reshape their operations to stay ahead of rapid technological shifts.

Company Size

10,001+

Company Stage

IPO

Headquarters

Dublin, Ireland

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • NVIDIA Inception partnership accelerates AI startups to enterprise scale.
  • Google Cloud Gemini program delivers pre-built AI agents for clients.
  • Federal Services secures $5.3B VA and weather contracts through 2030.

What critics are saying

  • ServiceNow partnership embeds engineers, capturing Accenture's implementation work.
  • Google Cloud accesses Accenture's AI agents, commoditizing proprietary IP.
  • Portfolio startups compete directly, eroding core consulting revenues by 2028.

What makes Accenture unique

  • Accenture Ventures deploys 5 I’s of Innovation lifecycle for 50,000 startups.
  • Accenture Ventures manages $250M fund with 70+ AI, SaaS investments.
  • Accenture Ventures Tech Next Challenge spotlights Autonomous AI startups.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Accenture who can refer or advise you

Benefits

Health Insurance

Professional Development Budget

401(k) Retirement Plan

401(k) Company Match

Company News

Yahoo Finance
Apr 14th, 2026
Accenture shares trade at lowest P/E since 2015 despite $117.75B market cap

Oakmark Fund highlighted Accenture in its first-quarter 2026 investor letter, identifying the professional services company as undervalued despite strong fundamentals. The fund outperformed the S&P 500 Index, returning -2.47% versus -4.33% for the index. Accenture, a global leader in consulting and IT services, is nearly three times larger than its next three public competitors combined. The company's top 300 clients spend over $100 million annually, and it is positioned to benefit from enterprise cloud transition and growing technology spending. Despite these strengths, Accenture trades at its lowest price-to-earnings multiple since 2015 due to AI disruption concerns. The stock closed at $191.95 on 13 April 2026, with a market capitalisation of $117.75 billion. Seventy-one hedge funds held positions in the company at the end of Q4.

Tech.eu
Apr 13th, 2026
Accenture and Google Cloud launch Brussels sovereign AI centre for regulated sectors

Accenture and Google Cloud have launched a Sovereign Centre in Brussels to help European governments and regulated sectors adopt AI whilst maintaining data control and regulatory compliance. The facility features Google Distributed Cloud air-gapped technology for organisations with strict sovereignty requirements. The centre enables organisations to design and validate AI solutions in secure environments, modernise legacy systems, and develop workforce skills. It provides a collaborative space for independent software vendors and partners to create proofs of concept and co-innovate on sovereign cloud applications. The launch follows growing European efforts to reduce dependence on non-European technology platforms. Recent initiatives include France's Visio videoconferencing tool and Germany's openDesk suite, whilst a coalition of European tech players recently launched Euro-Office as an open-source alternative to Microsoft's productivity suite.

Yahoo Finance
Apr 12th, 2026
UBS reaffirms buy on Accenture with $5.3B federal unit securing major VA and weather system contracts

Accenture Federal Services, a subsidiary of Accenture plc, has secured significant government contracts that strengthen the company's long-term growth prospects, according to UBS analyst Kevin McVeigh, who maintained a Buy rating with a $320 price target. AFS generated approximately $5.3 billion in fiscal year 2025, representing 8% of Accenture's total revenue. The unit recently won a 4.5-year contract with the US Department of Veterans Affairs to modernise electronic health records for over 9 million veterans, alongside a separate contract to upgrade the National Weather Service's weather system. McVeigh noted these multi-year contracts provide visibility as AFS recovers from recent budget pressures and government spending cuts. The subsidiary employs around 15,000 people and focuses on mission-critical technology solutions for US government agencies.

Surperformance
Apr 8th, 2026
Accenture acquires Spanish AI firm Keepler to scale data capabilities across EMEA

Accenture has acquired Keepler Data Tech, a Spanish cloud-native AI and data company founded in 2018, to expand its AI and data capabilities in Spain and beyond. Financial terms were not disclosed. Keepler offers end-to-end AI and data services, from strategy and cloud-native data foundations to advanced analytics and agentic AI deployment. The company focuses on industrialised delivery, ethics and compliance to help organisations modernise data architecture and implement DataOps and MLOps at scale. More than 240 Keepler professionals, including technical architects, data scientists and software engineers, will join Accenture. The company has offices in Madrid, London and Lisbon. The acquisition follows Accenture's recent purchases of AI companies including Faculty, Decho, RANGR Data, NeuraFlash and Halfspace as part of its ongoing investment in AI capabilities.

Yahoo Finance
Mar 26th, 2026
Accenture beats earnings for 4th quarter, stock positioned for AI-driven growth

Accenture has raised $120 million in a Series C round led by Ribbit Capital, valuing the company at $1.45 billion. Sequoia and Kleiner Perkins participated, with Emerson Collective joining as a new backer. The pre-revenue company is developing "Mathematical Superintelligence", focused on advanced reasoning that eliminates AI hallucinations by requiring outputs in Lean4 programming language for verification. Its Aristotle model achieved top performance at the International Mathematical Olympiad in July. Founded in 2023, Harmonic has raised $295 million across three rounds in 14 months. The company offers Aristotle via free API and plans to commercialise in safety-critical industries like aerospace and finance, where mistakes carry severe consequences.